# Dietary anthocyanidin pelargonidin activates G protein‐coupled receptor 35

**Authors:** Fumie Nakashima, Sayako Shimomura, Mayuka Wakabayashi, Wei Qi Loh, Harumi Ando, Haruka Sei, Hiroyuki Hattori, Didik Huswo Utomo, Masaki Kita, Asuka Inoue, Koji Uchida, Takahiro Shibata

PMC · DOI: 10.1111/febs.70311 · 2025-10-29

## TL;DR

Pelargonidin, a compound found in red fruits, activates a receptor called GPR35, which may help reduce inflammation and offer health benefits.

## Contribution

Pelargonidin is newly identified as a dietary agonist of GPR35, with specific structural interactions and anti-inflammatory effects.

## Key findings

- Pelargonidin is a potent GPR35 agonist among 3-hydroxyanthocyanidins.
- Pelargonidin inhibits interleukin-8 production in Caco-2 cells via GPR35 activation.
- Hydrogen bonding and hydrophobic interactions are crucial for pelargonidin's agonistic activity.

## Abstract

G protein‐coupled receptors (GPCRs) are the largest superfamily of cell surface receptors. They regulate critical physiological events and serve as potential therapeutic targets. G protein‐coupled receptor 35 (GPR35), a class A rhodopsin‐like GPCR expressed in various tissues, including adipose tissue and the gastrointestinal tract, has roles in diverse functions, including antioxidant, anticarcinogenic, and anti‐inflammatory effects. Although many endogenous and synthetic GPR35 agonists have been identified, the understanding of food‐derived agonists is limited. In this study, we discovered pelargonidin as a newly identified food‐derived GPR35 agonist through a systematic screening approach. We evaluated 28 dietary phytochemicals using a transforming growth factor α (TGFα) shedding assay to evaluate GPR35 activation, and found that cyanidin, a common 3‐hydroxyanthocyanidin present in various red fruits and vegetables, induced GPR35 activation. Among a series of 3‐hydroxyanthocyanidins tested, pelargonidin, characterized by its monohydroxylated B‐ring, exhibited the most potent agonistic activity. Mutational studies demonstrated that the hydrogen bond between the 3‐hydroxy group in the C‐ring of pelargonidin and Asn169, as well as the hydrophobic interaction between the A‐ring of pelargonidin and Phe163, is crucial for GPR35 activation. Furthermore, pelargonidin inhibited the production of interleukin‐8, a pro‐inflammatory cytokine, by activating endogenous GPR35 in Caco‐2 cells. These findings suggest that GPR35 may serve as a potential receptor for dietary anthocyanidins, such as pelargonidin, and provide new insights into the molecular mechanisms underlying the potential chemopreventive effects of anthocyanidins.

Pelargonidin, a red‐fruit‐derived anthocyanidin, was newly identified as a dietary agonist of GPR35, a metabolite‐sensing GPCR implicated in anti‐inflammation. Through screening of dietary compounds, pelargonidin emerged as a potent GPR35 agonist, attenuating inflammation in human intestinal cells. These findings highlight the therapeutic potential of anthocyanidins in modulating cellular defense mechanisms via GPR35 activation.

## Linked entities

- **Genes:** GPR35 (G protein-coupled receptor 35) [NCBI Gene 2859], TGFA (transforming growth factor alpha) [NCBI Gene 7039]
- **Chemicals:** pelargonidin (PubChem CID 440832), cyanidin (PubChem CID 128861), interleukin-8 (PubChem CID 74974005)

## Full-text entities

- **Genes:** GPR35 (G protein-coupled receptor 35) [NCBI Gene 2859], CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, TGFA (transforming growth factor alpha) [NCBI Gene 7039] {aka TFGA}
- **Diseases:** inflammatory (MESH:D007249)
- **Chemicals:** 3-hydroxyanthocyanidin (-), cyanidin (MESH:C017154), pelargonidin (MESH:C066957), anthocyanidin (MESH:D000872)
- **Cell lines:** Caco-2 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0025)

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12979022/full.md

---
Source: https://tomesphere.com/paper/PMC12979022